title: Choosing first-line therapy for management of type 2 diabetes.
authors.affiliation: University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. mark-graber@uiowa.edu
authors.forename: Mark A
authors.initials: MA
authors.lastname: Graber
authors.forename: Andrea
authors.initials: A
authors.lastname: Darby-Stewart
authors.forename: Robert
authors.initials: R
authors.lastname: Dachs
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin; D005905:Glyburide